Randomized, double‐blind, placebo‐controlled 8‐week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 72, Iss. 2, 2018-02 ,pp. : 64-72

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder

By Colonna Lucien   Andersen Henning Friis   Reines Elin Heldbo  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1659-1668

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study

By Zerbini C.   Ozturk Z. E.   Grifka J.   Maini M.   Nilganuwong S.   Morales R.   Hupli M.   Shivaprakash M.   Giezek H.    

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 2037-2049

Informa Healthcare

Access to resources Recommend Favorite

Safety and Effectiveness of 100 mg/kg/day Deferiprone in Patients with Thalassemia Major: A Two-Year Study

By  

Acta Haematologica, Vol. 114, Iss. 3, 2005-10 ,pp. : 146-149

Karger

Access to resources Recommend Favorite

Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression

By Cowen Philip J.   Ogilvie Alan D.   Gama Joubert  

Current Medical Research and Opinion, Vol. 21, Iss. 3, 2005-03 ,pp. : 345-356

Informa Healthcare

Access to resources Recommend Favorite